Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

49.84
+0.32000.65%
Post-market: 49.840.00000.00%17:41 EDT
Volume:1.21M
Turnover:60.11M
Market Cap:3.93B
PE:-10.54
High:50.33
Open:49.27
Low:48.45
Close:49.52
Loading ...

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Eli Lilly, Roku among others added to Wells Fargo's tactical ideas list

Investing.com
·
01 Apr

PTC Therapeutics Is Maintained at Overweight by JP Morgan

Dow Jones
·
31 Mar

PTC Therapeutics price target lowered to $75 from $78 at JPMorgan

TIPRANKS
·
31 Mar

U.S. RESEARCH ROUNDUP- Braze, Home Bancshares, Union Pacific

Reuters
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-GameStop, Oxford Industries, Wolfspeed

Reuters
·
29 Mar

BUZZ-PTC Therapeutics falls as EC to not renew market authorization for muscle disorder drug

Reuters
·
28 Mar

PTC Therapeutics says EC will not renew market authorization for muscle disorder drug

Reuters
·
28 Mar

PTC Therapeutics (PTCT) Gets a Hold from TD Cowen

TIPRANKS
·
28 Mar

PTC Therapeutics Loses EU Authorization for Translarna in Duchenne Muscular Dystrophy

MT Newswires Live
·
28 Mar

PTC Therapeutics Shares Fall After EU Drops Translarna Authorization

Dow Jones
·
28 Mar

PTC Therapeutics Shares Down 8.2% Premarket as Co's Muscle Disorder Therapy to Be Removed From European Markets

THOMSON REUTERS
·
28 Mar

PTC Therapeutics says European Commission will remove muscle disorder drug

Reuters
·
28 Mar

BRIEF-PTC Therapeutics Provides Regulatory Update On Translarna™ (Ataluren) In Europe

Reuters
·
28 Mar

PTC Therapeutics : Disappointed That After Prolonged Period of Review European Commission Has Decided to Adopt Chmp Negative Opinion on Translarna

THOMSON REUTERS
·
28 Mar

PTC Therapeutics Provides Regulatory Update on Translarna™ (Ataluren) in Europe

THOMSON REUTERS
·
28 Mar

PTC Therapeutics Inc: Look Forward to Working on a Country-by-Country Basis to Provide Commercial Drug Where Possible

THOMSON REUTERS
·
28 Mar

PTC Therapeutics Inc: This Action Effectively Removes Drug's Conditional Marketing Authorization in European Economic Area

THOMSON REUTERS
·
28 Mar

How to Play SRPT Stock After Patient Death Post DMD Therapy Infusion

Zacks
·
24 Mar

Promising Potential of PTC Therapeutics’ Sepiapterin in PKU Treatment Justifies Buy Rating

TIPRANKS
·
21 Mar